Clinical Trials Browser

Phase 2/3 × Lomustine × 1 year × Clear all

NCT03970447 2026-05-15

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Phase 2/3 Active not recruiting

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive